EQT reportedly proposes to acquire QIAGEN (QGEN.US) for over $50 per share, with KKR also participating in the bid.
智通财经2026/10/20 23:45Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to Golden Ten Data, insiders revealed that Swedish private equity firm EQT AB is in advanced negotiations to acquire the European molecular diagnostics company QIAGEN (QGEN.US), and has submitted a binding offer of over $50 per share. The insiders also stated that another private equity giant, KKR, is also participating in the bidding.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$75,917.4
+0.86%
Ethereum
ETH
$2,241.37
+1.20%
Tether USDt
USDT
$0.9987
+0.01%
BNB
BNB
$693.91
+1.05%
XRP
XRP
$1.17
-1.05%
USDC
USDC
$0.9997
+0.00%
Solana
SOL
$90.02
+0.87%
TRON
TRX
$0.3185
+0.04%
Zcash
ZEC
$1,314.2
+5.16%
Hyperliquid
HYPE
$79.1
+2.56%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now